4
Changes in Ownership
Mineralys Therapeutics, Inc. Filed Acc 0001933414-26-000058
Chief Medical Officer sold 20,406 shares at an average $26.61 ($542,973)
- Chief Medical Officer acquired 14,057 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Rodman David Malcom Chief Medical Officer | 2026-03-12 | Option exercise 10b5-1 | +6,348 | $1.08 | $6,856 | 88,837 | D |
| Rodman David Malcom Chief Medical Officer | 2026-03-12 | Sale 10b5-1 | −6,348 | $27.37 | $173,748 | 82,489 | D |
| Rodman David Malcom Chief Medical Officer | 2026-03-13 | Option exercise 10b5-1 | +3,542 | $10.20 | $36,128 | 86,031 | D |
| Rodman David Malcom Chief Medical Officer | 2026-03-13 | Option exercise 10b5-1 | +4,167 | $14.25 | $59,380 | 90,198 | D |
| Rodman David Malcom Chief Medical Officer | 2026-03-13 | Sale 10b5-1 | −10,726 | $25.91 | $277,922 | 79,472 | D |
| Rodman David Malcom Chief Medical Officer | 2026-03-13 | Sale 10b5-1 | −3,079 | $27.37 | $84,265 | 76,393 | D |
| Rodman David Malcom Chief Medical Officer | 2026-03-13 | Sale 10b5-1 | −253 | $27.82 | $7,038 | 76,140 | D |
| Derivatives | |||||||
| Rodman David Malcom Chief Medical Officer | 2026-03-12 | Option exercise · Stock Option 10b5-1 | −6,348 | 25,395 | D | ||
| Rodman David Malcom Chief Medical Officer | 2026-03-13 | Option exercise · Stock Option 10b5-1 | −3,542 | 123,959 | D | ||
| Rodman David Malcom Chief Medical Officer | 2026-03-13 | Option exercise · Stock Option 10b5-1 | −4,167 | 95,834 | D | ||
| Open-market sales · 20,406 sh · avg $26.61 · $542,973 | |||||||
Loading xslF345X05/wk-form4_1773696009.xml…